MAPT and Alzheimer disease: These findings underscore the potential of PBM as a therapeutic approach in AD, though further research is needed to explore its effects on NSC-exosome interactions, tau pathology, and motor networks, as well as to assess its feasibility and efficacy in human clinical trials.